Alaunos Therapeutics, Inc. (TCRT) › Net IncomeAlaunos Therapeutics, Inc. (TCRT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2004: -$5.69M2005: -$9.52M2006: -$17.86M2007: -$26.61M2008: -$25.23M2009: -$7.65M2010: -$32.67M2011: -$63.78M2012: -$96.13M2013: -$57.11M2014: -$31.78M2015: -$120.09M2016: -$165.30M2017: -$54.32M2018: -$53.12M2019: -$117.80M2020: -$79.98M2021: -$78.75M2022: -$37.73M2023: -$4.68M2024: -$4.68M2025: -$4.18M-$4.18M2004Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$4.18M+10.8%2024-$4.68M+0.0%2023-$4.68M+87.6%2022-$37.73M+52.1%2021-$78.75M+1.5%2020-$79.98M+32.1%2019-$117.80M-121.8%2018-$53.12M+2.2%2017-$54.32M+67.1%2016-$165.30M-37.6%2015-$120.09M-277.9%2014-$31.78M+44.3%2013-$57.11M+40.6%2012-$96.13M-50.7%2011-$63.78M-95.2%2010-$32.67M-327.1%2009-$7.65M+69.7%2008-$25.23M+5.2%2007-$26.61M-49.0%2006-$17.86M-87.6%2005-$9.52M-67.3%2004-$5.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share